PS 05-63 PRO- AND ANTI-INFLAMMATORY FACTORS AND VASCULAR STIFFNESS IN END-STAGE RENAL DISEASE PATIENTS

2016 ◽  
Vol 34 (Supplement 1) ◽  
pp. e158
Author(s):  
Botond Csiky ◽  
Endre Sulyok ◽  
Orsolya Lakatos ◽  
Attila Peti
2005 ◽  
Vol 67 (6) ◽  
pp. 2393-2398 ◽  
Author(s):  
Luisa Ibeiez ◽  
Merius Morlans ◽  
Xavier Vidal ◽  
Marea Jose Martanez ◽  
Joan-Ramon Laporte

2021 ◽  
Vol 12 (3) ◽  
pp. 2200-2206
Author(s):  
Dedy Pratama ◽  
Hendro Sudjono Yuwono ◽  
Rudi Supriyadi ◽  
Herry Herman ◽  
Avicenna Akbar ◽  
...  

The primary clinical problem of arteriovenous fistula (AVF) is the high maturation failure rate. Curcumin shows anti-inflammatory, antioxidant, antitumorigenic, and antiproliferative effects that may contribute to AVF maturation.  This study investigated the effectiveness of curcumin and acetylsalicylic acid on anti-inflammatory and antitumorigenic effects on AVF maturation in patients with End-Stage Renal Disease (ESRD) with diabetes mellitus (DM).  The present study is a single-blinded, randomized controlled trial consisting of curcumin, acetylsalicylic acid, or placebo intervention for eight weeks. A total of 67 participants completed the intervention. There was a higher level of nitric oxide (NO) between the curcumin and placebo four weeks (92.58±24.70 vs 75.67±16.50 µmol/L, adjusted p = 0.038) and eight weeks (95.27±28.77 vs 76.66±23.24 µmol/L, adjusted p <0.05) postoperatively. Higher-level of NO between acetylsalicylic acid and placebo (93.65±24.65 vs 75.67±16.50 µmol/L, adjusted p = 0.031) four weeks postoperatively. Curcumin increases NO after four and eight weeks and lowers MMP-9 four weeks after AVF operation. Acetylsalicylic acid increases NO four weeks after AVF surgery on ESRD patients with DM.


2006 ◽  
Vol 13 (Supplement 1) ◽  
pp. S72-S73
Author(s):  
AP Patrianakos ◽  
FI Parthenakis ◽  
D Karakitsos ◽  
E De Groot ◽  
G Lirarakis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document